A Severe and Prolonged Case of Ocular Monkeypox Without Systemic Manifestations
- PMID: 38870146
- DOI: 10.1097/ICO.0000000000003574
A Severe and Prolonged Case of Ocular Monkeypox Without Systemic Manifestations
Abstract
Purpose: The objective of this study was to present a rare case of prolonged and severe ocular monkeypox virus infection in the absence of systemic manifestations.
Methods: This was a single case report.
Results: A 60-year-old man, having been symptomatic for 9 days, presented with several umbilicated, ulcerated papules on the left cheek, left side of the nose, and left upper eyelid, along with marked follicular conjunctivitis and multiple conjunctival ulcerations. Two weeks after presentation, he developed an irregular, 360° circumferential opacity in the peripheral cornea that progressed to a large epithelial defect with corneal thinning. Although the initial eyelid lesions and conjunctivitis quickly resolved, the patient experienced nonresolving corneal inflammation manifest with peripheral corneal thinning, epithelial defects, and stromal keratitis. Four months after presentation, with the presumptive diagnosis of peripheral ulcerative keratitis, the patient was treated with intravenous steroids and immunosuppressive treatment, after which the ocular surface inflammation improved. However, the inflammation recurred 12 weeks later, and the patient developed severe perilimbal necrotizing conjunctivitis, followed by recurrence of ulcerated nodular eyelid lesions. Eight months after presentation, nucleic acid amplification tests from eyelid lesion swabs returned positive for nonvariola Orthopoxviruses , which led to the diagnosis of mpox. Within 2 weeks of beginning antiviral treatment with systemic tecovirimat and cidofovir and topical trifluridine, the eyelid lesions, conjunctivitis, and corneal inflammation resolved.
Conclusions: We present an unusual and challenging case of ocular mpox with severe ocular surface inflammation including peripheral corneal thinning and epithelial defects, without systemic disease. Initiation of antiviral treatment resulted in a quick resolution of the ocular disease.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
Comment in
-
Letter Regarding: A Severe and Prolonged Case of Ocular Monkeypox Without Systemic Manifestations.Cornea. 2024 Oct 1;43(10):e33-e34. doi: 10.1097/ICO.0000000000003632. Epub 2024 Jul 9. Cornea. 2024. PMID: 38984516 No abstract available.
References
-
- Sheryl Gay S, Mandavilli A. As Monkeypox Spreads, U.S. Declares a Health Emergency. The New York Times; 2022.
-
- Prevention CfDCa. U.S. Mpox Case Trends Reported to CDC. Available at: https://www.cdc.gov/poxvirus/mpox/response/2022/mpx-trends.html . Accessed December 15, 2023.
-
- Kumar N, Acharya A, Gendelman HE, et al. The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun. 2022;131:102855.
-
- Marennikova SS, Seluhina EM, Mal'ceva NN, et al. Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man. Bull World Health Organ. 1972;46:599–611.
-
- Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull. 1998;54:693–702.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
